Assessment of the Safety of ABT-308 in Healthy Volunteers and Subjects With Asthma.

Trial Profile

Assessment of the Safety of ABT-308 in Healthy Volunteers and Subjects With Asthma.

Completed
Phase of Trial: Phase I

Latest Information Update: 28 Apr 2017

At a glance

  • Drugs RPC 4046 (Primary) ; RPC 4046 (Primary)
  • Indications Asthma
  • Focus Adverse reactions; First in man
  • Sponsors Abbott Laboratories; AbbVie
  • Most Recent Events

    • 28 Apr 2017 Results published in the Advances in Therapy
    • 12 Apr 2011 Status changed from active, no longer recruiting to completed according to ClinicalTrials.gov record.
    • 17 Dec 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top